サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


mRNA Vaccines and Therapeutics Market Forecast 2019-2029

mRNAワクチンと治療薬市場予測2019−2029

レポート概要

mRNAワクチンと治療薬市場は2018年に34億3,000万ドルに達すると予想されます。2018年における標準化したがん治療mRNAワクチンのシェアは35.47%で、今後10年間に9.77%のCAGRで拡大する見込みで。

このレポートがもたらすメリット

読み進めるにつれてこのセクターに出現するビジネスチャンスを掴む方法が明らかになります。

この184ページのレポートに130の表とグラフを掲載‐これらは全て他のどこでも入手できないものです。

このレポートを利用することによってmRNAワクチンと治療薬市場について明確で詳細な見識を得ることができます。また市場の主な推進要因と課題が明らかになります。

レポート詳細

目次

1. Report Overview
1.1 Global mRNA Vaccines and Therapeutics Market Overview
1.2 Global mRNA Vaccines and Therapeutics Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Main Questions Answered by this Report
1.8 Who is this Report for?
1.9 Research and Analysis Methods
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Reports
1.12 About Visiongain

2. Introduction to mRNA Vaccines and Therapeutics
2.1 History of mRNA Vaccines & Therapeutics Development
2.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
2.3 Prevention and Treatment Using mRNA Vaccines & Therapeutics
2.3.1 mRNA Modifications
2.3.2 mRNA Efficiencies
2.3.3 Adjuvant/Stimulant & Carrier Technologies for mRNA-based Vaccines
2.3.4 Carriers for mRNA-based Protein & Antibody Therapeutics

3. Introduction of mRNA & Delivery Technologies
3.1 Ex vivo mRNA Loading
3.1.1 Arcelis Technology
3.1.2 Flow Electroporation Technology
3.2 In vivo Carrier & mRNA
3.2.1 Hybrid mRNA Technology
3.2.2 Lipid Nanoparticle (LNP) mRNA Technology
3.2.3 Nanotaxi Technology
3.2.4 RNArt & RNAntibody Technology
3.2.5 UNA & LUNAR Technologies
3.3 mRNA Vaccines & Stimulants / Adjuvants
3.3.1 RNActive Technology
3.3.2 Self-Amplifying mRNA (SAM) Technology
3.3.3 TriMix Technology

4. Global mRNA Vaccines & Therapeutics: Market Size and Forecast 2019-2029
4.1 mRNA Vaccines and Therapeutics Market Overview, 2018
4.2 The World mRNA Vaccines and Therapeutics Market
4.3 World mRNA Vaccines and Therapeutics Market: Sales Forecast 2019-2029
4.4 Changing Market Shares by Region 2018-2029

5. mRNA Vaccines and Therapeutics Market: Drivers, Restraints, and Trends Analysis 2019-2029
5.1 mRNA Vaccines and Therapeutics Market: Drivers 2019-2029
5.1.1 Rising Adoption of Personalized Medicine for Effective Treatment
5.1.2 Advantages Offered by mRNA-based Products
5.1.3 Rising Funding by Pharmaceutical Companies and Government Organizations
5.2 mRNA Vaccines and Therapeutics Market: Restraints 2019-2029
5.2.1 Delivery of mRNA therapeutics and vaccines
5.2.2 Stringent Government Regulations for mRNA-based Product Approvals
5.3 mRNA Vaccines and Therapeutics Market: Trends 2019-2029
5.3.1 Rising adoption of gene therapy-based products

6. mRNA Vaccines & Therapeutics by Type: Market Size and Forecast 2019-2029
6.1 Market Forecast 2019-2029
6.2 Market Share of mRNA Vaccines and Therapeutics by Type
6.2.1 Standardized Therapeutic Cancer mRNA Vaccines: Market Forecast, 2019-2029
6.2.2 Individualized Therapeutic Cancer mRNA Vaccines: Market Forecast, 2019-2029
6.2.3 Therapeutic Infectious Disease mRNA Vaccines: Market Forecast, 2019-2029
6.2.4 mRNA Therapeutic for Other Diseases: Market Forecast, 2019-2029

7. mRNA Vaccines & Therapeutics by Mechanism of Action: Market Size and Forecast 2019-2029
7.1 Market Forecast 2019-2029
7.2 Market Share of mRNA Vaccines and Therapeutics by Mechanism of Action
7.2.1 Bioengineered Vaccine: Market Forecast, 2019-2029
7.2.2 Gene Therapy (Gene Silencing/Suppression): Market Forecast, 2019-2029
7.2.3 Gene Transcription (Protein Generation): Market Forecast, 2019-2029
7.2.4 Cell Therapy: Market Forecast, 2019-2029
7.2.5 Monoclonal Antibody: Market Forecast, 2019-2029
7.2.6 Others: Market Forecast, 2019-2029

8. mRNA Vaccines & Therapeutics Regional Market: Market Size and Forecast 2019-2029
8.1 Leading National Markets of mRNA Vaccines & Therapeutics 2019-2029
8.2 North America mRNA Vaccines & Therapeutics: Market Size and Forecast 2019-2029
8.2.1 The US mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.2.2 Canada mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.3 Europe mRNA Vaccines & Therapeutics: Market Size and Forecast 2018-2029
8.3.1 Germany mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.3.2 UK mRNA Vaccines and Therapeutics Market: Forecast 2019-2029
8.3.3 French mRNA Vaccines and Therapeutics Market: Forecast 2019-2029
8.3.4 Italian mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.3.5 Spanish mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.4 Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Forecast 2019-2029
8.4.1 Japanese mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.4.2 Chinese mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.4.3 Indian mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.5 Row mRNA Vaccines & Therapeutics Market Size and Forecast 2018-2029
8.5.1 Brazilian mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.5.2 Mexico mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.5.3 Russia mRNA Vaccines and Therapeutics: Market Forecast 2019-2029
8.5.4 South Africa mRNA Vaccines and Therapeutics: Market Forecast 2019-2029

9. mRNA Vaccines & Therapeutics R&D Pipeline Analysis, 2018
9.1 Promising Pipeline Molecules Analysis
9.2 Standardized mRNA Cancer Vaccines
9.3 Therapeutic mRNA Infectious Disease Vaccines
9.4 Individualized mRNA Cancer Vaccines
9.5 Replicon RNA Infectious Disease Vaccines
9.6 Prophylactic mRNA Infectious Disease Vaccines
9.7 mRNA Protein Therapeutics for Ornithine TransCarbomylase Deficiency
9.8 mRNA Protein Therapeutics for Cancer and Cardiovascular Diseases
9.9 mRNA Protein Therapeutics for Cystic Fibrosis
9.10 mRNA Protein Therapeutics for Other Genetic Diseases
9.11 Therapeutic mRNA-based Gene Editing
9.12 mRNA Antibody Therapeutics

10. Leading Companies in the mRNA Vaccines and Therapeutics Market
10.1 Moderna Therapeutics
10.1.1 Product Portfolio
10.1.2 Financial Overview
10.1.3 Strategic Developments
10.2 Sangamo Therapeutics
10.2.1 Product Portfolio
10.2.2 Financial Overview
10.2.3 Strategic Developments
10.3 Argos Therapeutics
10.3.1 Product Portfolio
10.3.2 Financial Overview
10.3.3 Strategic Developments
10.4 CureVac
10.4.1 Product Portfolio
10.4.2 Financial Overview
10.4.3 Strategic Developments
10.5 Translate Bio
10.5.1 Product Portfolio
10.5.2 Financial Overview
10.5.3 Strategic Developments
10.6 BioNTech
10.6.1 Product Portfolio
10.6.2 Financial Overview
10.6.3 Strategic Developments
10.7 In-Cell-Art
10.7.1 Product Portfolio
10.7.2 Financial Overview
10.7.3 Strategic Developments
10.8 eTheRNA Immunotherapies
10.8.1 Product Portfolio
10.8.2 Financial Overview
10.8.3 Strategic Developments
10.9 ethris GmbH
10.9.1 Product Portfolio
10.9.2 Financial Overview
10.9.3 Strategic Developments
10.10 Tiba Biotech
10.10.1 Product Portfolio
10.10.2 Financial Overview
10.10.3 Strategic Developments

11. Conclusion
11.1 The World mRNA Vaccines and Therapeutics Market in 2018-2029
11.2 Current Leading mRNA Vaccines and Therapeutics Segments
11.3 Leading mRNA Vaccines and Therapeutics Companies
11.4 Leading Regional Markets

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form

List of Tables
Table 4.1 Global mRNA Vaccines and Therapeutics Market Forecast Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 6.1 Global mRNA Vaccines and Therapeutics Market Forecast by Type: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 6.2 Global Standardized Therapeutic Cancer mRNA Vaccines Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.3 Global Individualized Therapeutic Cancer mRNA Vaccines Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.4 Global Therapeutic Infectious Disease mRNA Vaccines Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 6.5 Global mRNA Therapeutic for Other Diseases Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.1 Global mRNA Vaccines and Therapeutics Market Forecast by Mechanism of Action: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 7.2 Global Bioengineered Vaccine Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.3 Global Gene Therapy (Gene Silencing/Suppression) Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.4 Global Gene Transcription (Protein Generation) Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.5 Global Cell Therapy Market Forecast: Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.6 Global Monoclonal Antibody Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 7.7 Global Other Mechanism of Actions Market Forecast Revenue ($bn), AGR (%), CAGR (%) 2019-2029
Table 8.1 World mRNA Vaccines and Therapeutics Market by Region: Revenue ($bn) and Market Share (%) 2018 and 2029
Table 8.2 Global mRNA Vaccines and Therapeutics Market Forecast by Region: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.3 North America mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.4 North America mRNA Vaccines and Therapeutics Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.5 US mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.6 Canada mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.7 Europe mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.8 Europe mRNA Vaccines and Therapeutics Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.9 Germany mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.10 UK mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.11 French mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.12 Italian mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.13 Spanish mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.14 Asia-Pacific mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.15 Asia-Pacific mRNA Vaccines and Therapeutics Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.16 Japanese mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.17 Chinese mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.18 Indian mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2029
Table 8.19 RoW mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.20 RoW mRNA Vaccines and Therapeutics Market Forecast by Country: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.21 Brazilian mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.22 Mexico mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.23 Russia mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 8.24 South Africa mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2019-2029
Table 9.1 Promising mRNA Vaccines and Therapies Pipeline Molecules Analysis, 2018
Table 9.2 Standardized mRNA Cancer Vaccines Pipeline Molecules Analysis, 2018
Table 9.3 Standardized mRNA Cancer Vaccines Pipeline Molecules Analysis, 2018
Table 9.4 Individualized mRNA Cancer Vaccines Pipeline Molecules Analysis, 2018
Table 9.5 Prophylactic mRNA Infectious Disease Vaccines Pipeline Molecules Analysis, 2018
Table 9.6 mRNA Protein Therapeutics for Ornithine TransCarbomylase Deficiency Pipeline Molecules Analysis, 2018
Table 9.7 mRNA Protein Therapeutics for Cancer and Cardiovascular Diseases Pipeline Molecules Analysis, 2018
Table 9.8 mRNA Protein Therapeutics for Cystic Fibrosis Pipeline Molecules Analysis, 2018
Table 9.9 mRNA Protein Therapeutics for Cystic Fibrosis Pipeline Molecules Analysis, 2018
Table 9.10 mRNA Protein Therapeutics for Cystic Fibrosis Pipeline Molecules Analysis, 2018
Table 9.11 mRNA Antibody Therapeutics Pipeline Molecules Analysis, 2018
Table 10.1 Overview: Moderna Therapeutics
Table 10.2 Moderna Therapeutics: Product Portfolio
Table 10.3 Recent Developments: Moderna Therapeutics
Table 10.4 Overview: Sangamo Therapeutics
Table 10.5 Sangamo Therapeutics: Product Portfolio
Table 10.6 Recent Developments: Sangamo Therapeutics, Inc.
Table 10.7 Overview: Argos Therapeutics
Table 10.8 Argos Therapeutics: Product Portfolio
Table 10.9 Recent Developments: Argos Therapeutics, Inc.
Table 10.10 Overview: CureVac
Table 10.11 CureVac: Product Portfolio
Table 10.12 Recent Developments: CureVac AG
Table 10.13 Overview: Translate Bio
Table 10.14 Translate Bio: Product Portfolio
Table 10.15 Recent Developments: Translate Bio
Table 10.16 Overview: BioNTech
Table 10.17 BioNTech: Product Portfolio
Table 10.18 Recent Developments: BioNTech
Table 10.19 Overview: In-Cell-Art
Table 10.20 In-Cell-Art: Product Portfolio
Table 10.21 Recent Developments: Translate Bio
Table 10.22 Overview: eTheRNA Immunotherapies
Table 10.23 eTheRNA Immunotherapies: Product Portfolio
Table 10.24 Recent Developments: Translate Bio
Table 10.25 Overview: Ethris GmbH
Table 10.26 Ethris GmbH: Product Portfolio
Table 10.27 Recent Developments: ethris GmbH
Table 10.28 Overview: Tiba Biotech
Table 10.29 Tiba Biotech: Product Portfolio

List of Figures
Figure 4.1 Global mRNA Vaccines and Therapeutics Market Forecast Revenue ($bn), AGR (%) 2019-2029
Figure 4.2 Global mRNA Vaccines and Therapeutics Market Forecast Share (%) by Region 2019-2029
Figure 5.1 mRNA Vaccines and Therapeutics Market: Drivers and Restraints 2019-2029
Figure 6.1 Global mRNA Vaccines and Therapeutics Market Forecast by Type: Revenue ($bn), 2019-2029
Figure 6.2 Global mRNA Vaccines and Therapeutics Market Forecast by Type: Market Share (%), 2019-2029
Figure 6.3 Global mRNA Vaccines and Therapeutics Market Forecast by Type: Market Shares (%), 2018
Figure 6.4 Global mRNA Vaccines and Therapeutics Market Forecast by Type: Market Shares (%), 2024
Figure 6.5 Global mRNA Vaccines and Therapeutics Market Forecast by Type: Market Shares (%), 2029
Figure 6.6 Global Standardized Therapeutic Cancer mRNA Vaccines Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.7 Global Individualized Therapeutic Cancer mRNA Vaccines Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.8 Global Therapeutic Infectious Disease mRNA Vaccines Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 6.9 Global mRNA Therapeutic for Other Diseases Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.1 Global mRNA Vaccines and Therapeutics Market Forecast by Mechanism of Action: Revenue ($bn) 2019-2029
Figure 7.2 Global mRNA Vaccines and Therapeutics Market Forecast by Mechanism of Action: Market Share (%) 2019-2029
Figure 7.3 Global mRNA Vaccines and Therapeutics Market Forecast by Mechanism of Action: Market Shares (%), 2018
Figure 7.4 Global mRNA Vaccines and Therapeutics Market Forecast by Mechanism of Action: Market Shares (%), 2024
Figure 7.5 Global mRNA Vaccines and Therapeutics Market Forecast by Mechanism of Action: Market Shares (%), 2029
Figure 7.6 Global Bioengineered Vaccine Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.7 Global Gene Therapy (Gene Silencing/Suppression) Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.8 Global Gene Transcription (Protein Generation) Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.9 Global Cell Therapy Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.10 Global Monoclonal Antibody Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 7.11 Global Other Mechanism of Actions Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.1 Global mRNA Vaccines and Therapeutics Market by Region: Revenues (%), 2018
Figure 8.2 Global mRNA Vaccines and Therapeutics Market by Region: Revenues (%), 2024
Figure 8.3 Global mRNA Vaccines and Therapeutics Market by Region: Revenues (%), 2029
Figure 8.4 North America mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.5 North America mRNA Vaccines and Therapeutics Market Forecast by Region: Share (%) 2019-2029
Figure 8.6 US mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.7 Canada mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.8 Europe mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.9 Europe mRNA Vaccines and Therapeutics Market by Country: Share (%), 2019-2029
Figure 8.10 Germany mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 8.11 UK mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.12 French mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.13 Italian mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.14 Spanish mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 8.15 Asia-Pacific mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.16 Asia-Pacific mRNA Vaccines and Therapeutics Market by Country: Share (%), 2019-2029
Figure 8.17 Japanese mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.18 Chinese mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.19 Indian mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2018-2029
Figure 8.20 RoW mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.21 RoW mRNA Vaccines and Therapeutics Market by Country: Share (%), 2018-2029
Figure 8.22 Brazilian mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.23 Mexico mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.24 Russia mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 8.25 South Africa mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn) and AGR (%), 2019-2029
Figure 10.1 Moderna Therapeutics: Financial Overview, 2016-2018
Figure 10.2 Sangamo Therapeutics: Financial Overview, 2016-2018
Figure 10.3 Argos Therapeutics: Financial Overview, 2016-2018
Figure 11.1 Global mRNA Vaccines and Therapeutics Market Forecast: Revenue ($bn), AGR (%) 2019-2029
Figure 11.2 Global mRNA Vaccines and Therapeutics Market Forecast by Country: Share (%) 2019-2029

発刊日

2019/05/07

体裁

PDF / 184ページ

販売価格

2,699GBP

発行

Visiongain

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

関連カテゴリ

医薬品原料・製剤 / バイオ・ゲノム・再生医療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE